Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines (Q40239125)

18 September 2017

Arginase induction by sodium phenylbutyrate in mouse tissues and human cell lines (English)

1 reference

18 September 2017

Kern RM

1

1 reference

18 September 2017

Yang Z

2

1 reference

18 September 2017

Kim PS

3

1 reference

18 September 2017

Grody WW

4

1 reference

18 September 2017

Iyer RK

5

1 reference

18 September 2017

Cederbaum SD

6

1 reference

18 September 2017

28 August 2006

1 reference

Molecular Genetics and Metabolism

18 September 2017

1 reference

18 September 2017

90

1 reference

18 September 2017

1

1 reference

18 September 2017

37-41

1 reference

Hyperargininemia due to liver arginase deficiency

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Hyperargininemia with Arginase Deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Immunologic studies of arginase in tissues of normal human adult and arginase-deficient patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Cloning and characterization of the human type II arginase gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage-like cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Human type II arginase: sequence analysis and tissue-specific expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Arginase deficiency manifesting delayed clinical sequelae and induction of a kidney arginase isozyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Differential expression of multiple forms of arginase in cultured cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Rat mammary arginase: isolation and characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Amino Acid Acylation: A Mechanism of Nitrogen Excretion in Inborn Errors of Urea Synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Pharmacological induction of peroxisomes in peroxisome biogenesis disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Induction of fetal hemoglobin synthesis in children with sickle cell anemia on low-dose oral sodium phenylbutyrate therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Molecular basis of phenotypic variation in patients with argininemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.07.002

10.1016/J.YMGME.2006.07.002

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference